Advances in predicting acute GVHD-Reference-Cited by-同舟云学术

Advances in predicting acute GVHD

Published:2012-12-04 Issue:3 Volume:160 Page:288-302
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Harris Andrew C.¹,Ferrara James L. M.¹,Levine John E.

Affiliation:

1. Blood and Marrow Transplant Program; Department of Pediatrics; C.S. Mott Children's Hospital; University of Michigan; Ann Arbor; MI; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12142/fullpdf

Reference102 articles.

1. Etanercept, mycophenolate, denileukin or pentostatin plus corticosteroids for acute graft vs. host disease: a randomized phase II trial from the BMT CTN;Alousi;Blood,2009

2. Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation;Ambruzova;Bone Marrow Transplantation,2009

3. Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial;Anasetti;Blood (ASH Annual Meeting Abstracts),2011

4. Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation?;Anasetti;Biology of blood and marrow transplantation,2012

5. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia;Arora;Journal of Clinical Oncology,2009

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alantolactone ameliorates graft versus host disease in mice;International Immunopharmacology;2024-02

2. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic;Cytotherapy;2023-08

3. Assessment of risk factors for acute graft-versus-host disease post-hematopoietic stem cell transplantation: a retrospective study based on a proportional odds model using a nonlinear mixed-effects model;Therapeutic Advances in Hematology;2023-01

4. A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation;Haematologica;2022-12-15

5. Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies;Frontiers in Oncology;2022-12-08